PEGS 2020

12 Annual PEGS Europe Virtual Summit 2020

9 Nov – 12 Nov 2020

Myriam Fabre, PhD. (Oncomatryx R&D Director) presentará en la Conferencia virtual, el próximo martes 10 de Noviembre, en la sesión incluida en la sección  “Next generation ADCs”:

OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models

También participará como moderadora en el Panel de Discusión que clausura la sesión: “Improving the therapeutic index in ADCs”

By continuing to use the site, you agree to the use of cookies. Continue, scroll or accept. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.